Topic List : Cancer

  • PET tracer predicts success of cancer ‘vaccine’

    With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer immunotherapy will be effective or not, according to a new Stanford study.

  • Multigene tests for breast cancer on the rise

    Tests to detect mutations in multiple genes are replacing BRCA-only analyses in women with breast cancer, according to a study by scientists at Stanford and several other institutions. Greater access to genetic counselors needed.

  • For ‘Project Lung,’ research gets personal

    When James Spudich was diagnosed with lung cancer, researchers had a rare, and unexpected, opportunity to study healthy and diseased human tissue at an unprecedented level of detail.

  • Henrietta Lacks family members speak

    Grandchildren of Henrietta Lacks, whose tissue sample became the source of the first immortalized cell line, spoke at an event featuring Rebecca Skloot, author of The Immortal Life of Henrietta Lacks.

  • $11.9 million for anti-leukemia trial

    The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.

  • Improving cancer care in Nigeria

    Stanford physicians are engaged in an ongoing and wide-ranging collaboration with the country’s ministry of health and doctors at major university-affiliated hospitals to improve several areas of cancer care.

  • Mom’s fundraising boosts tumor research

    Bereaved mother Mycah Clemons raised money for a summer scholarship at Stanford for research on diffuse intrinsic pontine glioma. The move sparked a series of experiments that have led to a possible treatment for the tumor.

  • Lung cancer patient back from the brink

    Eight years after being diagnosed with stage-4 lung cancer, whose treatment led to other health complications, Ginger Powell is cancer-free. “Being cared for at Stanford gives me so much hope,” she said.

  • Altered immune cells attack brain tumor

    In mice, a fatal brainstem tumor was cleared by injecting it with engineered T cells that recognized the cancer and targeted it for destruction. The Stanford discovery is moving to human trials.

  • Tracking cancer growth

    Cancer research that once involved years of painstaking work can now happen in months with a novel technique for studying cancer-related genes. The results reveal how combinations of mutations influence tumor growth.